论文部分内容阅读
研究人员通过对糖尿病患者的调查分析发现,给予糖尿病患者的睾酮替代疗法的益处还有待于进一步评估。近日,在第66届美国糖尿病学会科学年会(ADA)上,来自于 Auxilium 专业制药公司的一项研究报告指出异常低的睾酮水平可能与2型糖尿病进展相关联。这一数据的提出基于一项568例男性2型糖尿病患者参加的前瞻性筛查试验结果。研究发现与睾酮水平正常的2型糖尿病患者相比较,那些低水平
Researchers through the analysis of diabetic patients found that giving diabetes testosterone replacement therapy benefits need to be further evaluated. Recently, at the 66th American Diabetes Society Annual Meeting of the Science (ADA), a study from the Auxilium Specialty Pharmaceutical Company found that abnormally low levels of testosterone may be associated with the progression of type 2 diabetes. This data is based on the results of a prospective screening trial of 568 male patients with type 2 diabetes. The study found those with type 2 diabetes who had normal testosterone levels compared with those with low levels